Mark Lysyshyn

1.8k total citations
38 papers, 1.3k citations indexed

About

Mark Lysyshyn is a scholar working on Public Health, Environmental and Occupational Health, Toxicology and Epidemiology. According to data from OpenAlex, Mark Lysyshyn has authored 38 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Public Health, Environmental and Occupational Health, 24 papers in Toxicology and 15 papers in Epidemiology. Recurrent topics in Mark Lysyshyn's work include Opioid Use Disorder Treatment (27 papers), Forensic Toxicology and Drug Analysis (22 papers) and HIV, Drug Use, Sexual Risk (11 papers). Mark Lysyshyn is often cited by papers focused on Opioid Use Disorder Treatment (27 papers), Forensic Toxicology and Drug Analysis (22 papers) and HIV, Drug Use, Sexual Risk (11 papers). Mark Lysyshyn collaborates with scholars based in Canada, United States and Iran. Mark Lysyshyn's co-authors include Evan Wood, Karen McCrae, Lianping Ti, Kenneth W. Tupper, Samuel Tobias, Thomas Kerr, Jane A. Buxton, Edward Bernstein, Maxwell S. Krieger and Brandon D. L. Marshall and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Epidemiology and American Journal of Preventive Medicine.

In The Last Decade

Mark Lysyshyn

35 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Lysyshyn Canada	17	915	637	632	173	128	38	1.3k
Lianping Ti Canada	23	996 1.1×	1.3k 2.0×	398 0.6×	159 0.9×	107 0.8×	128	2.0k
Bryce Pardo United States	17	538 0.6×	479 0.8×	224 0.4×	224 1.3×	174 1.4×	39	961
R. Matt Gladden United States	10	602 0.7×	337 0.5×	208 0.3×	90 0.5×	153 1.2×	12	821
Michelle McKenzie United States	22	957 1.0×	964 1.5×	227 0.4×	86 0.5×	302 2.4×	54	1.4k
Chelsea L. Shover United States	18	565 0.6×	516 0.8×	218 0.3×	284 1.6×	215 1.7×	53	1.3k
Philipp Lobmaier Norway	14	404 0.4×	325 0.5×	108 0.2×	128 0.7×	115 0.9×	32	716
Isabelle Giraudon Portugal	18	264 0.3×	273 0.4×	400 0.6×	189 1.1×	77 0.6×	43	998
Sarah G. Mars United States	15	1.2k 1.3×	861 1.4×	420 0.7×	138 0.8×	332 2.6×	28	1.5k
Michael Gilbert United States	10	519 0.6×	314 0.5×	164 0.3×	52 0.3×	118 0.9×	21	713
Kirsten Wiese Simonsen Denmark	19	243 0.3×	211 0.3×	520 0.8×	213 1.2×	59 0.5×	45	994

Countries citing papers authored by Mark Lysyshyn

Since Specialization

Citations

This map shows the geographic impact of Mark Lysyshyn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Lysyshyn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Lysyshyn more than expected).

Fields of papers citing papers by Mark Lysyshyn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Lysyshyn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Lysyshyn. The network helps show where Mark Lysyshyn may publish in the future.

Co-authorship network of co-authors of Mark Lysyshyn

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Lysyshyn. A scholar is included among the top collaborators of Mark Lysyshyn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Lysyshyn. Mark Lysyshyn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tobias, Samuel, et al.. (2025). Detection of benzodiazepines in the unregulated drug supply using point of care and confirmatory drug checking technologies: A validation study. Drug and Alcohol Dependence. 271. 112631–112631.

Tobias, Samuel, Cameron Grant, Mark Lysyshyn, et al.. (2025). Sharing drug checking results in a Canadian setting: a multi-site analysis. International Journal of Drug Policy. 143. 104903–104903.

Marshall, Brandon D. L., Mark Lysyshyn, Cameron Grant, et al.. (2025). Impact of having a regular drug dealer on obtaining drug checking results consistent with expectations during a drug toxicity crisis in a Canadian setting. Drug and Alcohol Dependence. 274. 112751–112751.

Khalili, Malahat, Paxton Bach, Alexis Crabtree, et al.. (2024). Management of Amphetamine and Methamphetamine Use Disorders: A Systematic Review and Network Meta-analysis of Randomized Trials. International Journal of Mental Health and Addiction. 23(6). 4768–4786. 1 indexed citations

Tobias, Samuel, Mark Lysyshyn, Jane A. Buxton, et al.. (2023). What impact did the COVID-19 pandemic have on the variability of fentanyl concentrations in the Vancouver, Canada illicit drug supply? An interrupted time-series analysis. SHILAP Revista de lepidopterología. 1(1). e000197–e000197. 8 indexed citations

Dong, Huiru, Samuel Tobias, Jane A. Buxton, et al.. (2023). Fentanyl Concentration in Drug Checking Samples and Risk of Overdose Death in Vancouver, Canada. American Journal of Preventive Medicine. 66(1). 10–17. 14 indexed citations

Klaire, Sukhpreet, et al.. (2022). Take-home drug checking as a novel harm reduction strategy in British Columbia, Canada. International Journal of Drug Policy. 106. 103741–103741. 18 indexed citations

Socías, M. Eugenia, et al.. (2022). Examining fentanyl and its analogues in the unregulated drug supply of British Columbia, Canada using drug checking technologies. Drug and Alcohol Review. 42(3). 538–543. 13 indexed citations

Wood, Evan, et al.. (2021). Is expected substance type associated with timing of drug checking service utilization?: A cross-sectional study. Harm Reduction Journal. 18(1). 66–66. 13 indexed citations

10.

Ti, Lianping, et al.. (2021). An outbreak of novel psychoactive substance benzodiazepines in the unregulated drug supply: Preliminary results from a community drug checking program using point-of-care and confirmatory methods. International Journal of Drug Policy. 93. 103169–103169. 88 indexed citations

11.

Vijh, Rohit, Michael Otterstatter, Patricia Daly, et al.. (2021). Evaluation of a multisectoral intervention to mitigate the risk of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) transmission in long-term care facilities. Infection Control and Hospital Epidemiology. 42(10). 1181–1188. 15 indexed citations

12.

Tobias, Samuel, et al.. (2020). Drug checking identifies counterfeit alprazolam tablets. Drug and Alcohol Dependence. 218. 108300–108300. 43 indexed citations

13.

Ti, Lianping, Samuel Tobias, Nazlee Maghsoudi, et al.. (2020). Detection of synthetic cannabinoid adulteration in the unregulated drug supply in three Canadian settings. Drug and Alcohol Review. 40(4). 580–585. 19 indexed citations

14.

Ti, Lianping, Samuel Tobias, Mark Lysyshyn, et al.. (2020). Detecting fentanyl using point-of-care drug checking technologies: A validation study. Drug and Alcohol Dependence. 212. 108006–108006. 57 indexed citations

15.

Buxton, Jane A., Ashraf Amlani, Margot Kuo, et al.. (2019). The British Columbia Drug Overdose and Alert Partnership: Interpreting and sharing timely illicit drug information to reduce harms. SHILAP Revista de lepidopterología. 4(1). 4–9. 16 indexed citations

16.

McCrae, Karen, Samuel Tobias, Cameron Grant, et al.. (2019). Assessing the limit of detection of Fourier‐transform infrared spectroscopy and immunoassay strips for fentanyl in a real‐world setting. Drug and Alcohol Review. 39(1). 98–102. 72 indexed citations

17.

Galanis, Eleni, S. R. Sobie, Robert Balshaw, et al.. (2019). Projected local rain events due to climate change and the impacts on waterborne diseases in Vancouver, British Columbia, Canada. Environmental Health. 18(1). 116–116. 22 indexed citations

18.

Scheuermeyer, Frank, Eric Grafstein, Jane A. Buxton, et al.. (2018). Safety of a Modified Community Trailer to Manage Patients with Presumed Fentanyl Overdose. Journal of Urban Health. 96(1). 21–26. 6 indexed citations

19.

Karamouzian, Mohammad, et al.. (2018). Evaluation of a fentanyl drug checking service for clients of a supervised injection facility, Vancouver, Canada. Harm Reduction Journal. 15(1). 46–46. 151 indexed citations

20.

Krieger, Maxwell S., William C. Goedel, Jane A. Buxton, et al.. (2018). Use of rapid fentanyl test strips among young adults who use drugs. International Journal of Drug Policy. 61. 52–58. 132 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact